Profile	GDS4982 / 206002_at
Title	Non-Hodgkin’s lymphoma cell lines response to antibodies against CD20 or B-cell receptor
Organism	Homo sapiens

Graph caption help

Sample	Title	Value	Rank
GSM573726	OCILY18-Rituximab-4h-rep1	4.99	21
GSM573727	OCILY18-Rituximab-4h-rep2	2.04	9
GSM573728	OCILY18-Rituximab-4h-rep3	9.56	34
GSM573729	OCILY18-LT20-4h-rep1	6.43	27
GSM573730	OCILY18-LT20-4h-rep2	2.84	13
GSM573731	OCILY18-LT20-4h-rep3	7.76	29
GSM573735	OCILY18-anti-IgMFab2-4h-rep1	0.92	0
GSM573736	OCILY18-anti-IgMFab2-4h-rep2	7.78	32
GSM573737	OCILY18-anti-IgMFab2-4h-rep3	6.71	27
GSM573732	OCILY18-anti-IgM-4h-rep1	4.76	21
GSM573733	OCILY18-anti-IgM-4h-rep2	3.89	18
GSM573734	OCILY18-anti-IgM-4h-rep3	0.99	0
GSM573789	OCILY18-anti-IgG-4h-rep1
GSM573790	OCILY18-anti-IgG-4h-rep2	7.92	28
GSM573791	OCILY18-anti-IgG-4h-rep3	1.01	0
GSM573723	OCILY18-Isotype-4h-rep1	8.92	31
GSM573724	OCILY18-Isotype-4h-rep2	9.08	33
GSM573725	OCILY18-Isotype-4h-rep3	1.94	9
GSM573720	OCILY18-Control-4h-rep1	5.74	25
GSM573721	OCILY18-Control-4h-rep2	4.06	18
GSM573722	OCILY18-Control-4h-rep3	2.86	14
GSM573786	OCILY18-Control-4h-rep4	4.05	17
GSM573787	OCILY18-Control-4h-rep5	17.55	47
GSM573788	OCILY18-Control-4h-rep6	9.18	31
GSM573768	REC1-Rituximab-4h-rep1	8.09	31
GSM573769	REC1-Rituximab-4h-rep2	5.15	23
GSM573770	REC1-Rituximab-4h-rep3	7.38	27
GSM573765	REC1-LT20-4h-rep1	8.2	31
GSM573766	REC1-LT20-4h-rep2	2.11	9
GSM573767	REC1-LT20-4h-rep3	6.24	26
GSM573777	REC1-anti-IgMFab2-4h-rep1	5.27	23
GSM573778	REC1-anti-IgMFab2-4h-rep2	7.34	31
GSM573779	REC1-anti-IgMFab2-4h-rep3	5.39	23
GSM573762	REC1-anti-IgM-4h-rep1	12.62	44
GSM573763	REC1-anti-IgM-4h-rep2	1.02	0
GSM573764	REC1-anti-IgM-4h-rep3	5.96	26
GSM573771	REC1-anti-IgG-4h-rep1	10.06	38
GSM573772	REC1-anti-IgG-4h-rep2	4.92	24
GSM573773	REC1-anti-IgG-4h-rep3	5.24	22
GSM573759	REC1-Isotype-4h-rep1	7	27
GSM573760	REC1-Isotype-4h-rep2	10.15	35
GSM573761	REC1-Isotype-4h-rep3	4.16	18
GSM573774	REC1-RituximabFab2-4h-rep1	4.25	19
GSM573775	REC1-RituximabFab2-4h-rep2	9.38	34
GSM573776	REC1-RituximabFab2-4h-rep3	8.12	31
GSM573756	REC1-Control-4h-rep1	4.17	18
GSM573757	REC1-Control-4h-rep2	9.12	32
GSM573758	REC1-Control-4h-rep3	1.08	0
GSM573708	SUDHL4-Rituximab-4h-rep1	2.94	18
GSM573709	SUDHL4-Rituximab-4h-rep2	0.96	0
GSM573710	SUDHL4-Rituximab-4h-rep3
GSM573711	SUDHL4-LT20-4h-rep1	0.96	0
GSM573712	SUDHL4-LT20-4h-rep2	5.41	30
GSM573713	SUDHL4-LT20-4h-rep3	1.88	10
GSM573717	SUDHL4-anti-IgMFab2-4h-rep1	2.98	18
GSM573718	SUDHL4-anti-IgMFab2-4h-rep2	2	11
GSM573719	SUDHL4-anti-IgMFab2-4h-rep3	2.9	18
GSM573714	SUDHL4-anti-IgM-4h-rep1	6.88	35
GSM573715	SUDHL4-anti-IgM-4h-rep2	2.87	18
GSM573716	SUDHL4-anti-IgM-4h-rep3	0.98	0
GSM573780	SUDHL4-anti-IgG-4h-rep1	8.68	37
GSM573781	SUDHL4-anti-IgG-4h-rep2	10.14	39
GSM573782	SUDHL4-anti-IgG-4h-rep3	2.91	16
GSM573705	SUDHL4-Isotype-4h-rep1	5.76	31
GSM573706	SUDHL4-Isotype-4h-rep2	1.94	11
GSM573707	SUDHL4-Isotype-4h-rep3	1.89	11
GSM573702	SUDHL4-Control-4h-rep1	0.98	0
GSM573703	SUDHL4-Control-4h-rep2
GSM573704	SUDHL4-Control-4h-rep3	8.11	37
GSM573783	SUDHL4-Control-4h-rep4	1.02	0
GSM573784	SUDHL4-Control-4h-rep5	1.04	0
GSM573785	SUDHL4-Control-4h-rep6	8.87	37
GSM573744	Z138-Rituximab-4h-rep1	2	9
GSM573745	Z138-Rituximab-4h-rep2	3.77	19
GSM573746	Z138-Rituximab-4h-rep3	2.89	16
GSM573747	Z138-LT20-4h-rep1	4.07	20
GSM573748	Z138-LT20-4h-rep2	3.86	20
GSM573749	Z138-LT20-4h-rep3	2	9
GSM573753	Z138-anti-IgMFab2-4h-rep1	2.01	10
GSM573754	Z138-anti-IgMFab2-4h-rep2
GSM573755	Z138-anti-IgMFab2-4h-rep3	7.15	31
GSM573750	Z138-anti-IgM-4h-rep1	5.03	24
GSM573751	Z138-anti-IgM-4h-rep2	3.01	16
GSM573752	Z138-anti-IgM-4h-rep3	9.1	38
GSM573795	Z138-anti-IgG-4h-rep1	8.14	31
GSM573796	Z138-anti-IgG-4h-rep2	5.06	22
GSM573797	Z138-anti-IgG-4h-rep3	8.39	31
GSM573741	Z138-Isotype-4h-rep1	5.93	28
GSM573742	Z138-Isotype-4h-rep2	0.96	0
GSM573743	Z138-Isotype-4h-rep3	1.94	10
GSM573738	Z138-Control-4h-rep1
GSM573739	Z138-Control-4h-rep2	5.95	28
GSM573740	Z138-Control-4h-rep3	6.91	32
GSM573792	Z138-Control-4h-rep4	3.12	14
GSM573793	Z138-Control-4h-rep5	8.19	29
GSM573794	Z138-Control-4h-rep6	2.03	9